Fingerprint
Dive into the research topics of 'The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-controlled study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically